In Vivo Efficacy of Anti-CD20-Interferon-Gamma Fusion Protein Against Syngeneic B Cell Lymphoma Is Mediated By Natural Killer Cells

被引：0
|
作者：
Vasuthasawat, Alex [1 ]
Yamada, Reiko E. [2 ]
Trinh, Kham R. [1 ]
Rokni, Neiki [2 ]
Morrison, Sherie L. [1 ]
Timmerman, John M. [2 ]
机构：
[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-131890
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1575
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Genetically Engineered Natural Killer (NK) Cell Immunotherapy for Poor Risk B-Cell (CD20+) Leukemia and Lymphoma
    Chu, Yaya
    Ayello, Janet
    Hochberg, Jessica
    vandeVen, Carmella
    Murphy, James
    Stier, Andrew
    Cairo, Mitchell S.
    BLOOD, 2011, 118 (21) : 458 - 459
  • [22] Differential in vitro and in vivo antitumor effects mediated by anti-CD40 and anti-CD20 monoclonal antibodies against human B-cell lymphomas
    Funakoshi, S
    Longo, DL
    Murphy, WJ
    JOURNAL OF IMMUNOTHERAPY, 1996, 19 (02): : 93 - 101
  • [23] Intratumoral But Not Systemic Delivery of CpG Oligodeoxynucleotide Augments the Efficacy of Anti-CD20 Monoclonal Antibody Therapy Against B Cell Lymphoma
    Betting, David J.
    Yamada, Reiko E.
    Kafi, Kamran
    Said, Jonathan
    van Rooijen, Nico
    Timmerman, John M.
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (06) : 622 - 631
  • [24] Natural killer cell-mediated basal and interferon-enhanced cytotoxicity against liver cancer cells is significantly impaired under in vivo oxygen conditions
    Fink, T
    Ebbesen, P
    Koppelhus, U
    Zachar, V
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2003, 58 (06) : 607 - 612
  • [25] Defining Diffuse Large B-Cell Lymphoma Immunotypes by CD8+T Cells and Natural Killer Cells
    Qi, Jing
    Xu, Lu
    Huang, Dongping
    He, Hesheng
    Yao, Junping
    Zhang, Jing
    Xu, Youhai
    Yang, Li
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [26] Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis
    Ayalon, O.
    Hughes, E. A.
    Cresswell, P.
    Lee, J.
    Proceedings of the National Academy of Sciences of the United States of America, 95 (05):
  • [27] Sensitive Detection of the Natural Killer Cell-Mediated Cytotoxicity of Anti-CD20 Antibodies and Its Impairment by B-Cell Receptor Pathway Inhibitors
    Hassenrueck, Floyd
    Knoedgen, Eva
    Goeckeritz, Elisa
    Midda, Safi Hasan
    Vondey, Verena
    Neumann, Lars
    Herter, Sylvia
    Klein, Christian
    Hallek, Michael
    Krause, Guenter
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [28] MAb Therapy:: the use of anti-CD20 Abs -: In vitro and in vivo purging of B lymphoma cells from stem-cell products using anti-CD20 Abs
    Derigs, HG
    CYTOTHERAPY, 2000, 2 (06) : 445 - 453
  • [29] CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells in interferon-gamma independent manner and induces the activation of acquired immunity against murine hepatocellular carcinoma.
    Miyagi, T
    Takehara, T
    Suzuki, T
    Jinushi, M
    Ohnishi, C
    Tatsumi, T
    Hiramatsu, N
    Kanto, T
    Hayashi, N
    HEPATOLOGY, 2003, 38 (04) : 771A - 771A
  • [30] A NOVEL CYTOKINE-ANTIBODY FUSION PROTEIN, N-820, TO ENHANCE THE FUNCTIONS OF EX-VIVO EXPANDED NATURAL KILLER CELLS AGAINST BURKITT LYMPHOMA
    Chu, Y.
    Nayyar, G.
    Su, N.
    Rosenblum, J.
    Soon-Shiong, P.
    Lee, J.
    Safrit, J.
    Barth, M.
    Lee, D.
    Cairo, M.
    LEUKEMIA RESEARCH, 2022, 121 : S17 - S18
12345